These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 23163083)

  • 1. Taking the risk. Despite meningitis outbreak, some hospitals have little choice but to rely on compounding pharmacies.
    Lee J; Barr P
    Mod Healthc; 2012 Oct; 42(42):6-7, 16, 1. PubMed ID: 23163082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compounding interest: a tragedy caused by contaminated steroids turned the spotlight on compounding pharmacies.
    Hinkley KN
    State Legis; 2013 Jun; 39(6):22-3. PubMed ID: 23805443
    [No Abstract]   [Full Text] [Related]  

  • 3. How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreak.
    Teshome BF; Reveles KR; Lee GC; Ryan L; Frei CR
    J Am Pharm Assoc (2003); 2014; 54(4):441-5. PubMed ID: 25063265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulating compounding pharmacies after NECC.
    Outterson K
    N Engl J Med; 2012 Nov; 367(21):1969-72. PubMed ID: 23134357
    [No Abstract]   [Full Text] [Related]  

  • 5. Compounding pharmacies: a viable option, or merely a liability?
    O'Brien D; Cohen I; Kennedy DJ
    PM R; 2013 Nov; 5(11):974-81. PubMed ID: 24247017
    [No Abstract]   [Full Text] [Related]  

  • 6. Bipartisan effort. Dems, GOP call for investigation into outbreak.
    Zigmon J
    Mod Healthc; 2012 Oct; 42(42):7, 16. PubMed ID: 23163083
    [No Abstract]   [Full Text] [Related]  

  • 7. Sterile compounding: clinical, legal, and regulatory implications for patient safety.
    Qureshi N; Wesolowicz L; Stievater T; Lin AT
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1183-91. PubMed ID: 25443512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compounding parenteral nutrition: reducing the risks.
    Curtis C; Sacks GS
    Nutr Clin Pract; 2009; 24(4):441-6. PubMed ID: 19605798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sterile products: advances and challenges in formulation, manufacturing and regulatory aspects--a regulatory review perspective.
    Hussong D
    AAPS PharmSciTech; 2010 Sep; 11(3):1482-4. PubMed ID: 20845091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Compounding of ophthalmic drugs in the pharmacy. Special care must be taken!].
    Daniels R
    Pharm Unserer Zeit; 2010 Jul; 39(4):306-11. PubMed ID: 20589805
    [No Abstract]   [Full Text] [Related]  

  • 11. Adulteration of drugs and foods: compendial approaches to lowering risk.
    Abernethy DR; Sheehan C; Griffiths JC; Williams RL;
    Clin Pharmacol Ther; 2009 Apr; 85(4):444-7. PubMed ID: 18463621
    [No Abstract]   [Full Text] [Related]  

  • 12. Injectable immunotherapy: recommendations for safe allergen vial preparation in the office setting.
    Lay PC
    Curr Opin Otolaryngol Head Neck Surg; 2009 Jun; 17(3):223-5. PubMed ID: 19395969
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.